Novanta (NASDAQ:NOVT) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.07-2.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.00. The company issued revenue guidance of $610-614 million, compared to the consensus revenue estimate of $605.10 million.

A number of research firms recently weighed in on NOVT. BidaskClub lowered shares of Novanta from a hold rating to a sell rating in a research report on Wednesday, October 31st. ValuEngine upgraded shares of Novanta from a hold rating to a buy rating in a research report on Wednesday, October 31st. Finally, Zacks Investment Research lowered shares of Novanta from a buy rating to a hold rating in a research report on Wednesday, July 11th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of Hold and a consensus price target of $64.00.

Shares of NASDAQ NOVT traded up $1.84 during trading on Thursday, hitting $77.89. 186,556 shares of the company were exchanged, compared to its average volume of 229,029. The firm has a market capitalization of $2.56 billion, a P/E ratio of 48.68 and a beta of 1.72. Novanta has a 1 year low of $43.65 and a 1 year high of $78.85. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.14 and a current ratio of 3.18.

Novanta (NASDAQ:NOVT) last issued its earnings results on Tuesday, November 6th. The technology company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.52 by $0.09. The company had revenue of $160.79 million for the quarter, compared to analyst estimates of $154.43 million. Novanta had a net margin of 6.18% and a return on equity of 19.30%. The business’s revenue was up 9.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.45 EPS. On average, sell-side analysts forecast that Novanta will post 2.1 earnings per share for the current fiscal year.

In related news, CFO Robert Buckley sold 13,487 shares of the business’s stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $72.90, for a total value of $983,202.30. Following the sale, the chief financial officer now directly owns 157,027 shares in the company, valued at approximately $11,447,268.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Peter L. Chang sold 3,680 shares of the business’s stock in a transaction dated Friday, August 17th. The stock was sold at an average price of $70.63, for a total transaction of $259,918.40. Following the completion of the sale, the vice president now owns 36,132 shares in the company, valued at $2,552,003.16. The disclosure for this sale can be found here. Insiders have sold a total of 37,167 shares of company stock worth $2,723,121 over the last 90 days. Insiders own 6.70% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Novanta (NOVT) Updates FY18 Earnings Guidance” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.thecerbatgem.com/2018/11/08/novanta-novt-updates-fy18-earnings-guidance.html.

Novanta Company Profile

Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.

Featured Article: Why is Cost of Capital Important?

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.